These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20556834)

  • 41. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis.
    Arrieta O; Rodriguez-Diaz JL; Rosas-Camargo V; Morales-Espinosa D; Ponce de Leon S; Kershenobich D; Leon-Rodriguez E
    Cancer; 2006 Oct; 107(8):1852-8. PubMed ID: 16967451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of diclofenac sodium in chronic active hepatitis and alcoholic cirrhosis.
    Lill JS; O'Sullivan T; Bauer LA; Horn JR; Carithers R; Strandness DE; Lau H; Chan K; Thakker K
    J Clin Pharmacol; 2000 Mar; 40(3):250-7. PubMed ID: 10709153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of iron load on fibrogenesis in chronic hepatitis C.
    Casaril M; Stanzial AM; Tognella P; Pantalena M; Capra F; Colombari R; Corrocher R
    Hepatogastroenterology; 2000; 47(31):220-5. PubMed ID: 10690612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of interferon alpha and prednisolone on the serum concentrations of the aminoterminal domain of procollagen type III(PIIIP) and type IV (7-S collagen) in patients with chronic hepatitis B.
    Hayasaka A; Kohen H; Yoshikawa N; Iida S; Ohto M
    J Hepatol; 1993 Aug; 19(1):36-42. PubMed ID: 8301040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment with colchicine and survival of patients with ascitic cirrhosis: a double-blind randomized trial.
    Adhami JE; Basho J
    Panminerva Med; 1998 Mar; 40(1):75-81. PubMed ID: 9573762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
    Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of serum 7S collagen in various liver diseases.
    Yamada S; Suou T; Kawasaki H; Yoshikawa N
    Clin Biochem; 1992 Dec; 25(6):467-70. PubMed ID: 1335851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study].
    Reinhardt M; Jorke D; Jahn G; Krombholz B; Müller A; Machnik G; Kunath H
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(5):257-75. PubMed ID: 3542496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III.
    Serejo F; Costa A; Oliveira AG; Ramalho F; Batista A; De Moura MC
    Dig Dis Sci; 2001 Aug; 46(8):1684-9. PubMed ID: 11508668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Procollagen-type III peptide serum concentrations in alcoholic and non-alcoholic liver disease.
    Monarca A; Petrini C; Perolini S; Pozzi F; Adelasco L; Natangelo R; Croce G
    Ric Clin Lab; 1985; 15(2):167-71. PubMed ID: 4059796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Collagen peptidase and type III procollagen peptide serum levels in chronic liver diseases.
    Müller A; Krombholz B; Pott G; Machnik G; Vollandt R; Reinhardt M; Jorke D
    Clin Chim Acta; 1991 Feb; 197(1):59-66. PubMed ID: 1646085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
    Solís-Herruzo JA; Morillas JD; Vargas J; Colina F; Castellano G; Muñoz Yagüe T; Estenoz J
    Med Clin (Barc); 1992 May; 99(1):1-5. PubMed ID: 1602891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
    Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
    Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Connective tissue components of the normal and fibrotic human liver. II. Clinical aspects.
    Pott G; Rauterberg J; Voss B; Gerlach U
    Klin Wochenschr; 1982 Jan; 60(1):1-7. PubMed ID: 7043067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity.
    McCullough AJ; Stassen WN; Wiesner RH; Czaja AJ
    Hepatology; 1987; 7(1):49-54. PubMed ID: 3492417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease.
    Misaki M; Shima T; Yano Y; Sumita Y; Kano U; Murata T; Watanabe S; Suzuki S
    Clin Chem; 1990 Mar; 36(3):522-4. PubMed ID: 2311224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial.
    Cortez-Pinto H; Alexandrino P; Camilo ME; Gouveia-Oliveira A; Santos PM; Alves MM; Moura MC
    Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):377-81. PubMed ID: 11943949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical study on treatment of liver fibrosis in patients of hepatitis B by kangxian baogan decoction].
    Liang TJ; Zhang W; Zhang CQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 May; 22(5):332-4. PubMed ID: 12584827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The effect of colchicine on liver function tests and hepatic fibrosis in patients with chronic active hepatitis: a study of 3 cases (author's transl)].
    de O e Silva A; Leandro PA; Brandão JF; Saldanha LB; Pontes JF
    Arq Gastroenterol; 1978; 15(3):123-9. PubMed ID: 749848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Colchicine in chronic liver disease of alcoholic etiology. Double-blind, randomized study of its effects on blood levels of plasma proteins and clinical course in patients].
    Parise ER; Chehter L; Nogueira MD; Leite-Mór MM; Neves JR; Ciuffardi G; Vilela MP
    Rev Assoc Med Bras (1992); 1995; 41(3):207-12. PubMed ID: 8574231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.